Streptomyces toyocaensis Nishimura et al. (ATCC® 19814)

Strain Designations: ISP 5030 [278, CBS 567.68, IFO 12824, RIA 1094]  /  Type Strain: no  /  Biosafety Level: 1

Permits and Restrictions

View Permits

Strain Designations ISP 5030 [278, CBS 567.68, IFO 12824, RIA 1094]
Produces aminoacylase I aminoacylase, aminoacylase 1
Produces toyocamycin toyokamycin
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Preceptrol® no
Type Strain no
Referred to as the type strain
Medium ATCC® Medium 196: Yeast malt extract agar
Growth Conditions
Temperature: 26.0°C
Name of Depositor EB Shirling
Chain of Custody
ATCC <<--EB Shirling<<--H. Nishimura 278

Nishimura H, et al. Toyocamycin, a new anti-Candida antibiotics. J. Antibiot. 9A: 60-62, 1956.

Takeuchi T, et al. Process for microbial production of an optically active 3-(3,4-dihydroxyphenyl) serine. US Patent 4,699,879 dated Oct 13 1987

Japanese Patent 323,049

Shirling EB, Gottlieb D. Cooperative description of type cultures of Streptomyces. II. Species descriptions from first study. Int J Syst Bacteriol 18: 69-189, 1968.

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation